Company intelligence / Profile preview

Cedience

Toronto, Ontario, Canadacedience.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Cedience has developed and commercialized an AI-driven SaaS platform that enables biopharma companies to rapidly access, analyze, and visualize complex regulatory data. The platform helps users answer questions about past approvals, clinical endpoints, regulator feedback on modalities like monoclonal antibodies or cell therapies, and more—reducing research time from days to minutes. No clinical results are reported as the company does not conduct trials itself.

Therapeutic areas: Other
Modalities: Not applicable (Cedience does not develop therapeutics; it provides regulatory intelligence software for drug development teams)
Industry: Drug Discovery Services

Partnerships

No specific major pharmaceutical or biotech partnerships publicly listed.

Beyond the preview

Go deeper on Cedience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cedience.

Explore the full profile